Skip to main content
TipRanks
Go Ultimate75% OFF

HCA Healthcare (2BH) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

2BH Analyst Ratings

Moderate Buy
16Ratings
8Buy7Hold1Sell
Based on 16 analysts giving stock ratings to HCA Healthcare in the past 3 months

2BH Stock 12 Month Forecast

CHF384.20â–¼(-8.14% Downside)
Based on 16 Wall Street analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is CHF 384.20 with a high forecast of CHF 470.49 and a low forecast of CHF 313.66. The average price target represents a -8.14% change from the last price of CHF 418.24.
Highest Price TargetCHF470.49Average Price TargetCHF384.20Lowest Price TargetCHF313.66

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CH:2BH
Price TargetArticle
Mizuho SecuritiesCHF408.59→CHF470.49buy12.49%UpsideReiterated11/11/26
Bank of America Securities―hold―Reiterated11/05/26
BernsteinCHF351.63→CHF388.78hold-7.04%DownsideReiterated11/04/26
Wells FargoCHF314.49→CHF386.30hold-7.64%DownsideReiterated11/02/26
Morgan StanleyCHF313.66sell-25.00%DownsideAssigned10/29/26
BarclaysCHF319.44→CHF331.00hold-20.86%DownsideReiterated10/29/26
RBC CapitalCHF409.41→CHF430.05buy2.82%UpsideReiterated10/29/26
KeyBancCHF404.46buy-3.29%DownsideReiterated10/28/26
BMO CapitalCHF408.59buy-2.31%DownsideReiterated10/28/26
Robert W. BairdCHF324.39→CHF337.60hold-19.28%DownsideReiterated10/28/26
Oppenheimer Analyst forecast on CH:2BHUnknown AnalystNot RankedOppenheimerCHF400.33buy-4.28%DownsideReiterated10/28/26
TD CowenCHF379.70→CHF401.16buy-4.08%DownsideReiterated10/28/26
Raymond James―hold―Reiterated09/28/26
JefferiesCHF371.44buy-11.19%DownsideReiterated09/17/26
Leerink Partners―buy―Reiterated09/17/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
QUITAchieve Life Sciences
PALIPalisade Bio
KRSAKorsana Biosciences
HELPHelus Pharma
IRLAIRulya Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering HCA Healthcare

3 Months
Sarah James
Sarah JamesCantor Fitzgerald
Success Rate15/19 ratings generated profit
79%
Average Return
+8.16%

Copying Sarah James's trades and holding each position for 3 Months would result in 78.95% of your transactions generating a profit, with an average return of +8.16% per trade.

1 Year
Ann Hynes
Ann HynesMizuho Securities
Success Rate27/27 ratings generated profit
100%
Average Return
+22.89%

Copying Ann Hynes's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +22.89% per trade.

2 Years
Whit Mayo
Whit MayoLeerink Partners
Success Rate47/47 ratings generated profit
100%
Average Return
+54.68%

Copying Whit Mayo's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +54.68% per trade.

2BH Analyst Recommendation Trends

020406080Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for 2BH
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy11100
Buy2525261514
Hold1519191512
Sell22211
Strong Sell00000
total4347483127

In the current month, 2BH has received 14 Buy Ratings, 12 Hold Ratings, and 1 Sell Ratings. 2BH average Analyst price target in the past 3 months is 384.20.

2BH Financial Forecast

CHF4CHF5CHF6CHF7CHF8Q1 2026Q3 2026Q4 2026
HighCHF7.02
ConsensusCHF6.75
LowCHF6.41

2BH Earnings Forecast

Next quarter’s earnings estimate for 2BH is CHF 6.75 with a range of CHF 6.41 to CHF 7.02. The previous quarter’s EPS was CHF 5.96. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

CHF15.8BCHF16BCHF16.3BCHF16.5BCHF16.7BQ1 2026Q3 2026Q4 2026
HighCHF16.7B
ConsensusCHF16.5B
LowCHF16.3B

2BH Sales Forecast

Next quarter’s sales forecast for 2BH is CHF 16.52B with a range of CHF 16.26B to CHF 16.75B. The previous quarter’s sales results were CHF 16.38B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

2BH Stock Forecast FAQ

What is CH:2BH’s average 12-month price target, according to analysts?
Based on analyst ratings, HCA Healthcare’s 12-month average price target is CHF384.20.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HCA Healthcare a Buy, Sell or Hold?
HCA Healthcare has a consensus rating of Moderate Buy, which is based on 8 buy ratings, 7 hold ratings and 1 sell ratings.
What is HCA Healthcare’s share price target?
The average share price target for HCA Healthcare is CHF384.20. This is based on 16 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF470.49, and the lowest forecast is CHF313.66. The average share price target represents a 8.14% decrease from the current price of CHF418.236.
What do analysts say about HCA Healthcare?
HCA Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 16 Wall Street analysts.
How can I buy shares of HCA Healthcare?
To buy shares of CH:2BH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.